Open AccessSimultaneous intraocular and cutaneous extranodal NK/T‐cell lymphoma refractory to multiple therapies including pembrolizumab
Author(s) -
Mallal Peter,
Ammanuel Benhur,
White Rohen,
Kennedy Chris,
Cheah Chan Yoon
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.4194
Subject(s) - medicine , intraocular lymphoma , pembrolizumab , lymphoma , refractory (planetary science) , dermatology , uveitis , neuro ophthalmology , pathology , ophthalmology , cancer , immunotherapy , physics , astrobiology , glaucoma
Key Clinical Message Floaters or visual disturbance in a patient with ENKL should prompt evaluation for possible vitreoretinal involvement. Lymphoma with ocular involvement should be treated aggressively and in most cases heralds CNS involvement.